CALL US: 888-704-8700 | Publicly traded as DIRV | Subscribe to Our Newsletter

CALL US: 888-704-8700 | Publicly traded as DIRV | Subscribe to Our Newsletter

Markets: Investors Looking Toward Renewed Momentum – Research on Directview Holdings, OxySure Therapeutics, Canacol Energy and Badger Daylighting

NEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Directview Holdings Inc. (DIRV), OxySure Therapeutics Inc. (OXYS), Canacol Energy Ltd. (CNNEF) and Badger Daylighting Ltd. (BADFF). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

DIRV Research Package: http://www.traders-choice.com/pdf?s=DIRV

OXYS Research Package: http://www.traders-choice.com/pdf?s=OXYS

CNNEF Research Package: http://www.traders-choice.com/pdf?s=CNNEF

BADFF Research Package: http://www.traders-choice.com/pdf?s=BADFF

============

Highlights from today’s reports include:

On Friday, March 11, 2016, NASDAQ Composite ended at 4,748.47, up 1.85%, Dow Jones Industrial Average advanced 1.28% to finish the day at 17,213.31, and the S&P 500 closed at 2,022.19, up 1.64%.

– DirectView Holdings Inc.’s stock edged lower by 3.33% to close Friday’s session at USD 0.0029. The company’s shares oscillated between USD 0.0026 and USD 0.0032. The stock recorded a trading volume of 10.96 million shares, which was above its 50-day daily average volume of 7.96 million shares and above its 52-week average volume of 6.51 million shares. Over the last three days DirectView Holdings Inc.’s shares have advanced 16.00%. Furthermore, over the last three months the stock has lost 40.82% and in the past six months the shares have shed 35.56%. DirectView Holdings Inc. is trading at a price to sales of 1.88 and the stock has a beta of 6.81. The 52-week trading range of the stock is between USD 0.0016 – USD 0.021.

– The stock of OxySure Therapeutics Inc. gained 1.11% to close Friday’s session at USD 0.08. The shares of the company moved in the range of USD 0.08 and USD 0.10, marking a new 52-week low during the session. A trading volume of 0.87 million shares was recorded, which was greater than its 150-day daily average volume of 0.19 million shares and above its 52-week average volume of 0.14 million shares. Over the last five days OxySure Therapeutics Inc.’s shares have declined by 36.95% and in the past one month the stock has lost 45.03%. Additionally, over the last three months the stock has declined 67.76% and in the past six months the shares have registered a loss of 78.45%. OxySure Therapeutics Inc. is trading at a price to sales of 0.86 and the stock has a beta of 1.32.

– Canacol Energy Ltd.’s stock increased by 1.82% to close Friday’s session at USD 2.49. The company’s shares fluctuated in the range of USD 2.49 and USD 2.58. A total of 0.12 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.53 million shares but was above its 52-week average volume of 0.05 million shares. Over the last three days Canacol Energy Ltd.’s shares have declined by 2.55% and in the past one week the stock has moved down 8.92%. Furthermore, over the last three months the stock has gained 36.73% and in the past six months the shares have picked up 34.00%. The company has returned 30.00% in the past three months and 35.28% in the last half year, on a compounded total return basis. Further, the company is trading at a price to book ratio of 4.92 compared to its historical PB ratio of 0.82. Additionally, the stock is trading at a price to earnings ratio of 22.68, a price to cash flow ratio of 90.74 and price to sales ratio of 13.19. Further, the stock has a beta of 2.44.

– Badger Daylighting Ltd.’s stock added 1.82% to close Friday’s session at USD 19.97. The share price vacillated between USD 19.68 and USD 20.49. The stock recorded a trading volume of 0.02 million shares, which was below its 50-day daily average volume of 0.17 million shares. Over the last five days Badger Daylighting Ltd.’s shares have declined by 0.19% while in the past one month the stock has gained a momentum of 13.75%. In addition, over the last three months the stock has gained 14.06% and year to date the shares have picked up 12.35%. The company has returned 21.22% in the past one month and 16.87% in the past one year, on a compounded total return basis. Badger Daylighting Ltd. has a current dividend yield of 1.36%. Further, the company is trading at a price to earnings ratio of 17.84 and a price to book ratio of 3.95. This compares to a historical PE ratio of 18.45 and its historical PB ratio of 4.37. Additionally, the stock is trading at a price to cash flow ratio of 9.53 and price to sales ratio of 2.37. Further, the stock has a beta of 1.13.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

Posted in